such as Caspase-3 and -7, which execute the apoptotic programme. The release of Smac/DIABLO and HtrA2/ Omi from the mitochondria appears to facilitate caspase activation by relieving active caspases from the repression imposed by inhibitor of apoptosis (IAP) proteins (Green, 2000) . Mice with targeted deletion apaf1 or caspase-9 exhibit developmental defects, and fibroblasts or thymocytes derived from these mice are profoundly protected against stress-or DNA damage-induced apoptosis (Cecconi et al., 1998; Hakem et al., 1998; Kuida et al., 1998; Yoshida et al., 1998) . The release of mitochondrial apoptogenic factors is regulated by the Bcl-2 family of proteins. Enforced expression of antiapoptotic Bcl-2 or Bcl-x L protects against stress-induced apoptosis in vitro and in vivo (Strasser et al., 1994; Minn et al., 1999) . Conversely, overexpression of proapoptotic Bcl-2 proteins, such as Bax, Bak or Bim, induces mitochondrial cytochrome c release and apoptosis in vitro (O'Connor et al., 1998; Finucane et al., 1999) . Mice with combined genetic deficiencies of bax and bak show severe developmental defects, which are explained by a lack of apoptosis in several tissues (Lindsten et al., 2000) .
The exact mechanism whereby Bcl-2 family proteins function in the release of mitochondrial apoptogenic factors still is unclear. It has been proposed that Baxtype proteins form pores or openings into the outer mitochondrial membrane, which allow the escape of cytochrome c and other factors from the mitochondrial intermembrane space into the cytoplasm (Saito et al., 2000; Kuwana et al., 2002) . This activity supposedly is counteracted by antiapoptotic Bcl-2-type proteins. Hence, a downregulation of Bcl-2 levels could tip the balance from cell survival towards cell death. Accordingly, a decline in Bcl-2 protein levels has been observed in several experimental systems of stressor DNA damage-induced apoptosis, and it is thought that this event precedes the release of mitochondrial apoptogenic factors and the activation of effector caspases.
Several mechanisms were proposed how Bcl-2 is negatively regulated by stress stimuli. Among others, these include a downregulation of bcl-2 mRNA (Chen et al., 1995) , p53-dependent repression of the bcl-2 promoter (Miyashita et al., 1994) and proteasomal degradation of Bcl-2 (Dimmeler et al., 1999; Dunkern et al., 2001 ). On the other hand, Bcl-2 and Bcl-x L themselves are caspase substrates (Fujita et al., 1998; Kirsch et al., 1999) , an observation that could place the decline of these antiapoptotic proteins more downstream in the apoptotic cascade. Many studies on Bcl-2 regulation devised pharmacologic inhibitors to dissect the order of events during stress-induced apoptosis. This strategy bears the risk of nonspecific inhibitory effects at the dose levels applied. In order to overcome these limitations, we applied a genetic model to study a possible contribution of Bcl-2 downregulation to DNA damage-induced apoptosis of murine fibroblasts.
Early passage mouse embryonic fibroblasts (MEF) derived from apaf1-deficient embryos and littermate wild-type (wt) controls were retrovirally transduced to express the oncogenes E1A and H-ras. This shifts the stress response of MEF from cell cycle arrest and senescence towards apoptosis (Lowe et al., 1993) . Treating apaf1 À/À and wt MEF with various DNAdamaging agents including UV radiation, g-radiation, etoposide, actinomycin D, doxorubicine, cisplatin and paclitaxel ( Figure 1a , and not shown), we confirmed that oncogene-expressing apaf1 À/À MEF are profoundly protected against these apoptotic stimuli. This is explained by the inefficient activation of executioner caspases in response to DNA damage in apaf1 À/À MEF ( Figure 1b ). If DNA damage would induce downregulation of Bcl-2 upstream of the release of mitochondrial apoptogenic factors, then a decrease of Bcl-2 protein should be equally found in apaf1 À/À and wt MEF. However, expression levels of Bcl-2 remained unchanged in apaf1 À/À MEF treated with various DNAdamaging agents at dose levels, which in wt MEF readily lead to a decrease in Bcl-2 protein ( Figure 2a ). To exclude a possible impact of the expression of oncogenes on Bcl-2 stability in our experimental system, spontaneously immortalized apaf1 À/À and wt MEF were treated with DNA-damaging agents. In the absence of oncogenes, apaf1 À/À MEF were also protected against the loss of Bcl-2 protein (Figure 2b, upper panel) . Moreover, the decrease of Bcl-2 protein in wt MEF was effectively prevented by the broad-spectrum caspase inhibitor zVAD-fmk ( Figure 2b , lower panel). Taken together, these data support the hypothesis that the decline of Bcl-2 protein levels found in wt MEF is a secondary event, and most likely reflects a cleavage of Bcl-2 by zVAD-inhibitable caspases or other proteinases, which are activated during apoptotic cell death.
If the decline of antiapoptotic Bcl-2 is not necessary for the DNA damage-induced release of mitochondrial apoptogenic factors, the question arises whether the activation of proapoptotic Bcl-2 proteins might be the initiating event during this process. The proapoptotic Bcl-2 family comprises 'multidomain' members, such as Bax or Bak, and the 'BH3-only' members, such as Bid, Bim, Noxa or Puma (Huang and Strasser, 2001) . Recent genetic evidence suggests that the BH3 proteins indirectly act on mitochondria by activating Bax-type proteins (Lindsten et al., 2000; Cheng et al., 2001) . DNA damage can lead to a p53-dependent induction of . Cells extracts were obtained after 24 h, and DEVD-pNA-cleavage was determined using a commercially available assay (Oncogene), Substrate cleavage was measured every 5 min during a 30 min incubation at 371C. The resulting slope indicates the DEVD-cleaving activity (mainly caspase-3) of each extract the BH3 protein Noxa in fibroblasts (Oda et al., 2000; Schuler et al., 2003) . Accordingly, we found by real-time RT-PCR that DNA damage equally induced noxa RNA expression in wt and apaf1 À/À MEF, whereas no significant changes in bcl-2 RNA expression were detected (Figure 3a) . It was further shown that the activation of proapoptotic Bax during apoptosis induced by stress or truncated Bid results in a specific conformational change, which is followed by the translocation of Bax from the cytoplasm to the mitochondria (Deshager et al., 1999; Nechushtan et al., 1999) . To this end, we studied the exposure of the activation-associated Bax epitope in apaf1 À/À and wt MEF by indirect immunofluorescence using a conformation-specific antiserum. Both, apaf1 À/À and wt MEF exhibit a change in Bax conformation following treatment with DNA-damaging agents (Figure 3b) . Moreover, in treated MEF of both genotypes, Bax clusters in a perinuclear punctate pattern (Figure 3b) .
As the lack of downregulation of Bcl-2 might result in an impaired release of mitochondrial apoptogenic factors in apaf1 À/À MEF, we next examined the release of cytochrome c in treated apaf1 À/À and wt MEF by indirect immunofluorescence, and cellular fractionation and immunoblotting (Figure 3b,c) . These experiments confirmed that cytochrome c is released upon DNA damage at the same rate and extent in apaf1 À/À and wt MEF.
The loss of the mitochondrial transmembrane potential Dc m is another consequence of the apoptotic mitochondrial outer membrane permeabilization by Bax-type proteins. Analysing apaf1 À/À and wt MEF treated with DNA-damaging agents or radiation, we found that the drop of Dc m equally occurs in MEF of both genotypes (Figure 3d ). This confirms previous observations that the loss of Dc m during stress-induced apoptosis proceeds upstream of zVAD-inhibitable caspase activation (Bossy-Wetzel et al., 1998) . Recently, a zVAD-resistant caspase activity has been proposed to act upstream of mitochondria during stress-induced apoptosis (Lassus et al., 2002; Marsden et al., 2002) . It remains open, whether DNA damage induces such an activity in our experimental system. However, it appears not to be sufficient to result in a decrease in Bcl-2 protein expression, which in oncogene-expressing MEF requires Apaf1-dependent activation of effector caspases.
Taken together, our results argue against a primary role of the regulation of Bcl-2 levels in the initiation of the caspase cascade during DNA damage-induced apoptosis of fibroblasts. A decline in Bcl-2 protein only occurs secondary to the activation of effector caspases. As it has been reported that caspase-cleaved Bcl-2 obtains proapoptotic effects (Kirsch et al., 1999) , the degradation of Bcl-2 could act in an amplification loop late during apoptotic caspase activation. Different stimuli, such as growth factor withdrawal in haematopoietic cells or T-cell activation, can very well change the pro-and antiapoptotic rheostat by regulating the expression of antiapoptotic genes, such as Bcl-x L . In DNA damage-induced apoptosis of fibroblasts, however, we find no support for a primary role of Bcl-2 downregulation.
In contrast, the induction of proapoptotic Noxa, the activation of Bax, the release of mitochondrial cytochrome c, and the loss of Dc m occur independently, and thus upstream of Apaf1-dependent activation of effector caspases. This suggests that DNA strand breaks trigger apoptosis in oncogene-expressing MEF via the proapoptotic Bcl-2 family proteins. This can proceed À/À and wt (not shown) MEF were plated in fibronectin-coated Thermanox chamber slides (Nunc), and were treated with 0.125 mm actinomycin D or 6.25 mm etoposide (not shown) for 16 h. Cells were fixed, permeabilized and stained as previously described . Primary antibodies against cytochrome c (Cyto c, 7H8.2C12, BD Pharmingen) and the Bax N-terminus (Bax-NT, Upstate) were incubated overnight at 41C, and FITC-(Cyto c, green) or Texas Red-conjugated (Bax-NT, red) secondary antibodies were used. Nuclei were counterstained with Hoechst 33342 (blue), and images were taken on an Olympus IX-70 fluorescence microscope. Note the appearance of perinuclear Bax-NT-positive clusters, and the change of the granular cytochrome c stain to a diffuse distribution following treatment. À/À and wt MEF were obtained at various time points following etoposide treatment (3.125 mm) as previously described (Schuler et al., 2000) . The distribution of cytochrome c was detected by SDS-PAGE and immunoblotting. (d) Oncogene-expressing apaf1 À/À and wt MEF were treated with etoposide (upper panel) or UV radiation (lower panel). Before analysis, cells were stained with the mitochondrial dye tetramethylrhodamine ethylester (TMRE, Molecular Probes, 75 nm for 30 min), and nuclei were counterstained with Hoechst 33342. Images were taken as in (a) (TMRE-red, Hoechstblue); note wt MEF with condensed nuclei and absent TMRE signal, and apaf1 À/À MEF with absent TMRE signal following etoposide (VP-16) treatment (upper panel). The percentage of TMRE high cells 24 h after UV radiation was quantitated by flow cytometry. Mean values and standard deviations of three independent experiments are given (lower panel) through the p53 tumour suppressor protein, which directly transactivates bax (Miyashita and Reed, 1995) , and which indirectly activates Bax through BH3 proteins, such as Noxa or PUMA (Oda et al., 2000; Nakano and Vousden, 2001; Schuler et al., 2003) . In addition, p53-independent mechanisms of activation of BH3 proteins and Bax or Bak exist, which still remain to be elucidated.
